BioVie Inc. Effective Income Tax Rate Reconciliation, Tax Settlement, Amount
BioVie Inc. (BIVI) reported Effective Income Tax Rate Reconciliation, Tax Settlement, Amount of -$22.07 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-13.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationTaxSettlements · last filed 2026-08-13
- BioVie Inc. effective income tax rate reconciliation, tax settlement, amount for fiscal 2026 was -$22.07M.
- BioVie Inc. effective income tax rate reconciliation, tax settlement, amount for fiscal 2025 was -$17.54M.
| Period end | Effective Income Tax Rate Reconciliation, Tax Settlement, Amount 12 month |
|---|---|
| 2026-06-30 | -$22.07M 10-K · filed 2026-08-13 |
| 2025-06-30 | -$17.54M 10-K · filed 2026-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |